Skip to content

The Mobile Health and Wellness Program Remote Health Study

MHWP Remote Health and Wellness Study

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07075978
Enrollment
40
Registered
2025-07-20
Start date
2025-07-17
Completion date
2026-09-01
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Self Management Education, Hypertension Self-management, Self Management

Keywords

Older adults, Remote patient monitoring, Telehealth, Interprofessional

Brief summary

This clinical trial trial design will be a pretest-posttest comparison group pilot study that evaluates the implementation of team-based telemedicine visits and remote patient monitoring.

Interventions

The usual interprofessional program activities are delivered via remote patient monitoring kits. The kit includes a tablet for virtual visits with the Mobile Health and Wellness Team and access to educational videos, as well as at-home monitoring devices for blood pressure, blood sugar if diabetic, pulse ox if COPD, and/or weight scale.

BEHAVIORALTelephone

The usual interprofessional program activities are delivered via telephone visits without any at-home monitoring devices.

Sponsors

Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant in the Mobile Health and Wellness Program * 18 years old or over * Reporting with hypertension, diabetes, congestive heart failure, or chronic obstructive pulmonary disease * English-speaking * Currently taking blood pressure and/or diabetes medications * Capable of engaging with the Health Recovery Solutions (HRS) Remote Patient Monitoring (RPM) device or participating in standard telephone-based care.

Exclusion criteria

* Prior diagnosis of Dementia; Alzheimer's disease, Lewy body, Parkinson's, or vascular dementia. * No access to an internet connection.

Design outcomes

Primary

MeasureTime frameDescription
PROMIS Self-Efficacy for Managing Chronic ConditionsBaseline, 8 weeks and through the end of participation at 16 weeksChange in self-efficacy in managing chronic conditions at 16 weeks, the tool will be the PROMIS Self-Efficacy for Managing Chronic Conditions - The PROMIS Self-Efficacy scoring system is designed to assess the confidence of individuals in managing their health and daily activities. It is based on a T-score metric, where a score of 10 points corresponds to one standard deviation (SD) from the mean. The PROMIS scoring system has a mean of 50 and a standard deviation (SD) of 10 in the US General Population. A score of 40 is one SD lower than the mean, while a score of 60 is one SD higher. This scoring system is used to evaluate the self-efficacy for managing chronic conditions and daily activities, providing a standardized way to measure and compare the effectiveness of interventions and treatments.
The Medical Outcomes Study (MOS) Measures of Patient AdherenceBaseline, 8 weeks and through the end of participation at 16 weeksImproved adherence to medical recommendations at 16 weeks, the tool will be The Medical Outcomes Study (MOS) Measures of Patient Adherence is a 5-item scale to assess the adherence of patients with chronic conditions to medical recommendations. To score a Medical Outcomes Study (MOS) survey, you first need to recode the raw survey responses according to the specific scale's rules. Then, you average the recoded item scores to get a subscale score. For an overall index, you average the scores for all relevant items. Finally, you can transform these average scores to a 0-100 scale, where 100 represents the best possible score.
The REALM Health LiteracyBaseline, 8 weeks and through the end of participation at 16 weeksChange in health literacy at 16 weeks, The REALM Health Literacy - Short Form is a 7-item assessment tool that is a validated rapid measure of health literacy. It is a 7-item word recognition test to screen a patient's health literacy quickly. The patient is asked to read the words aloud. Scores are interpreted into a reading grade level equivalent, takes about one minute and requires minimal training.
Change in mobile device proficiency at 16 weeksBaseline, 8 weeks and through the end of participation at 16 weeksThe Mobile Device Proficiency (MDPQ-16) is a 16-item survey measuring participants' ability to operate a mobile device. First, assign a numerical value from 1 to 5 to each item, with one being "Never Tried" and five being "Very Easily". Next, calculate the average score for each of the eight subscales (Mobile Device Basics, Communication, Data and File Storage, Internet, Calendar, Entertainment, Privacy, and Troubleshooting/Software Management). Finally, add the eight subscale averages to obtain a total score ranging from 8 to 40.

Secondary

MeasureTime frameDescription
Change in blood pressureBaseline, 8 weeks and through the end of participation at 16 weeksChange in blood pressure (SBP/DBP) over the course of the 16 weeks, particularly for baseline to post-study in the remote group. Blood pressure is measured in units of millimeters of mercury (mmHg). The readings are always given in pairs, with the upper (systolic) value first, followed by the lower (diastolic) value.
Change in weightBaseline, 8 weeks and through the end of participation at 16 weeksChange in weight over the course of the 16 weeks, particularly for baseline to post study in the remote group.
Change in blood oxygenationBaseline, 8 weeks and through the end of participation at 16 weeksMeasured by a pulse oximeter over the course of the 16 weeks, particularly for baseline to post-study in the remote group. (No range outcome necessary- continuous value)
Change in blood glucoseBaseline, 8 weeks and through the end of participation at 16 weeksChange in blood glucose over the course of the 16 weeks, particularly for baseline to post study in the remote group.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLana Sargent

Virginia Commonwealth University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026